The New York Course 2021 Virtual

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

The New York Course 2021 Virtual

Event
Videos

Playback speed

10 seconds

Do Broadly Neutralizing Antibodies Show Promise as Long Acting Agents for Treatment and Prevention of HIV-1?

By The New York Course 2021 Virtual FEATURING Daniel Kuritzkes

9 views

July 6, 2021

Comments 0

Videos

HIV Treatment Guidelines, Developments, and Studies: Can Neutralizin…

The New York Course 2021 Virtual

M. Cohen

73 views

Combination Prevention for COVID-19: What Lessons from the HIV Pande…

The New York Course 2021 Virtual

M. Cohen

7 views

COVID-19 Monoclonal Antibody Applications: How Have Variants Affecte…

The New York Course 2021 Virtual

M. Cohen

1.3K views

HIV Treatment Case Studies: Challenges, Causes, Implications, and Tr…

The New York Course 2021 Virtual

P. Sax

60 views

HIV-Associated Non-alcoholic Fatty Liver Disease: Diagnosis, Testing…

The New York Course 2021 Virtual

R. Chung

9 views

40 Years of HIV: Trials, Triumphs, and What's to Come

The New York Course 2021 Virtual

A. Levine

9 views

Diabetes Management: How to Manage Diabetes in Persons Living With H…

The New York Course 2021 Virtual

T. Brown

149 views

HIV Prevention and Combination Prevention for COVID-19

The New York Course 2021 Virtual

M. Cohen

6 views

Hepatitis C Elimination: What Are the Current Recommendations for Me…

The New York Course 2021 Virtual

O. Falade-Nwulia

33 views

HIV Prevention and Transmission: How Do Current Behavioral and Biome…

The New York Course 2021 Virtual

L. Mena

Quantification of Hepatic Fibrosis: How to Evaluate

The New York Course 2021 Virtual

J. Reinus

110 views

Do Broadly Neutralizing Antibodies Show Promise as Long Acting Agent…

The New York Course 2021 Virtual

D. Kuritzkes

9 views

Bamlanivimab for Prevention of COVID-19 and Emerging Resistance to V…

The New York Course 2021 Virtual

D. Kuritzkes

1.2K views

Is the COVID-19 Pandemic a Catalyst for Differentiated Care Models t…

The New York Course 2021 Virtual

W. Armstrong

12 views

Patients With Drug Resistant HIV: Unmet Needs for Prevention and Ben…

The New York Course 2021 Virtual

R. Bedimo

2021 Syphilis Treatment Guidelines: How Common Are Repeat Infections?

The New York Course 2021 Virtual

J. Marrazo

34 views

2021 Update to CDC’s Treatment Guidelines for Gonococcal Infection: …

The New York Course 2021 Virtual

J. Marrazo

84 views

2021 Update on STI-PEP and STI Immunizations

The New York Course 2021 Virtual

J. Marrazo

11 views

COVID-19 in Patients With HIV: Overview of Presenting Characteristic…

The New York Course 2021 Virtual

R. Gulick

7 views

COVID-19 and HIV: What Are the Recommendations for Triage, Managemen…

The New York Course 2021 Virtual

R. Gulick

545 views

How is HBV Cure Defined? Is HBsAg Decline a Useful Intermediate Endp…

The New York Course 2021 Virtual

C. Thio

Hepatitis B Infection: Is a Cure Achievable Based on Current Therapi…

The New York Course 2021 Virtual

C. Thio

9 views